Skip to main content
Signal8

RegeneRx Biopharmaceuticals, Inc. (RGRX)

RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.

Sector: Biotechnology

Industry: Biotechnology

RegeneRx Biopharmaceuticals, Inc. logo

RegeneRx Biopharmaceuticals, Inc.

OTC:RGRXHealthcare
CLOSED
Mkt Cap-
EV-
Float836K
O/S1.5M
VOL251 sh
$ Vol$0
Inst Own-
Net Cash/Sh-
Dilution
Short interest (FINRA)
Not computed yet: no FINRA short interest has been matched to this float.

Float 836.25K · FMP free float

6
Sep 15 (428d)prev 6– 0.0%
1.00
Sep 15 (428d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow RGRX shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver

No price or settlement history available to chart.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for RGRX: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually